Professor Dan Siskind
Professor

Dan Siskind

Email: 
Phone: 
+61 7 3176 2860

Background

Prof Siskind trained as a psychiatrist in Australia and the United States. He graduated from medicine at the University of Queensland in 1998. After working with Doctors Without Borders in Chechnya in 2000, he became interested in psychiatry. He moved to Boston in 2002, where he did his psychiatry residency at Boston University and a Master of Public Health at Harvard University. He returned to Brisbane in June 2008 as a clinical academic psychiatrist at the Metro South Addiction and Mental Health Service. He completed his Ph.D in Feb 2014. His research interests include clozapine and treatment refractory schizophrenia, the physical health of people with severe and persistent mental illness, supported accommodation, assertive community treatment and mental health services research. He has been awarded an NHMRC Investigator Grant as an Emerging Leadership Fellow (2021-2025) and held an NHMRC Early Career Fellowship (2016-2019). He has a current CIA MRFF RCRDUN grant looking at treatments to reduce cardiometabolic morbidity among people with schizophrenia. He has over 200 peer reviewed publications, including first author in the highly ranked Lancet, World Psychiatry, Lancet Psychiatry, BJPsych, ANZJP, & Schizophrenia Bulletin. He is a named investigator on over $40 million in competitive research grants, with over $6 million as CIA.

Availability

Professor Dan Siskind is:
Available for supervision
Media expert

Fields of research

Health Sciences Psychology

Research interests

  • Schizophrenia

  • Physical Health Comorbidity

Search Professor Dan Siskind’s works on UQ eSpace

376 works between 2007 and 2025
All (376) Journal Article (286) Book Chapter (1) Conference Publication (83) Other Outputs (6)

41 - 60 of 376 works

2024

Journal Article

Research Letter: The state of academic psychiatry in Aotearoa New Zealand and Australia: Data from a survey of the Royal Australian and New Zealand College of Psychiatrists membership

Northwood, Korinne, Eggleston, Katherine, Every-Palmer, Susanna, Galbally, Megan, Warren, Nicola, Berk, Michael, Gill, Neeraj, Siskind, Dan and Suetani, Shuichi (2024). Research Letter: The state of academic psychiatry in Aotearoa New Zealand and Australia: Data from a survey of the Royal Australian and New Zealand College of Psychiatrists membership. Australian & New Zealand Journal of Psychiatry, 58 (6), 48674241240592-539. doi: 10.1177/00048674241240592

Research Letter: The state of academic psychiatry in Aotearoa New Zealand and Australia: Data from a survey of the Royal Australian and New Zealand College of Psychiatrists membership

2024

Journal Article

Comments on “Prevalence and predictors of QTc prolongation in patients seen in a clozapine clinic in a real-world setting in Australia”

Tanzer, Timothy, Winckel, Karl, Isoardi, Katherine, Smith, Lesley, Andric, Teodora and Siskind, Dan (2024). Comments on “Prevalence and predictors of QTc prolongation in patients seen in a clozapine clinic in a real-world setting in Australia”. Schizophrenia Research, 264, 370-371. doi: 10.1016/j.schres.2024.01.003

Comments on “Prevalence and predictors of QTc prolongation in patients seen in a clozapine clinic in a real-world setting in Australia”

2024

Journal Article

Associations of the gut microbiome with treatment resistance in schizophrenia

Vasileva, Svetlina S., Yang, Yuanhao, Baker, Andrea, Siskind, Dan, Gratten, Jacob and Eyles, Darryl (2024). Associations of the gut microbiome with treatment resistance in schizophrenia. JAMA Psychiatry, 81 (3), 292-302. doi: 10.1001/jamapsychiatry.2023.5371

Associations of the gut microbiome with treatment resistance in schizophrenia

2024

Journal Article

A longitudinal birth cohort study of child maltreatment and mental disorders using linked statewide child protection and administrative health data for 83,050 Queensland residents from 1983 to 2014

Kisely, Steve, Leske, Stuart, Ogilvie, James, Thompson, Carleen, Siskind, Dan and Allard, Troy (2024). A longitudinal birth cohort study of child maltreatment and mental disorders using linked statewide child protection and administrative health data for 83,050 Queensland residents from 1983 to 2014. Epidemiology and Psychiatric Sciences, 33 e69, e69-e77. doi: 10.1017/s204579602400074x

A longitudinal birth cohort study of child maltreatment and mental disorders using linked statewide child protection and administrative health data for 83,050 Queensland residents from 1983 to 2014

2024

Journal Article

Metformin co-commencement at time of antipsychotic initiation for attenuation of weight gain: a systematic review and meta-analysis

Yu, Ou, Lu, Mengyao, Lai, Terence K. Y., Hahn, Margaret, Agarwal, Sri Mahavir, O’Donoghue, Brian, Ebdrup, Bjørn H. and Siskind, Dan (2024). Metformin co-commencement at time of antipsychotic initiation for attenuation of weight gain: a systematic review and meta-analysis. Therapeutic Advances in Psychopharmacology, 14, 1-11. doi: 10.1177/20451253241255476

Metformin co-commencement at time of antipsychotic initiation for attenuation of weight gain: a systematic review and meta-analysis

2024

Other Outputs

TRS-BIOME

Eyles, Darryl, Vasileva, Svetlina, Siskind, Dan, Alexander, Suzy, Gratten, Jake, Ko, Pauline and Vasileva, Svetlina (2024). TRS-BIOME. The University of Queensland. (Dataset) doi: 10.48610/23fd2eb

TRS-BIOME

2024

Journal Article

Rates of colorectal cancer diagnosis and mortality in people with severe mental illness: results from Australia’s National Bowel Cancer Screening Programme

Kisely, S., Spilsbury, K., Bull, C., Jordan, S., Kendall, B. J., Siskind, D., Sara, G., Protani, M. and Lawrence, D. (2024). Rates of colorectal cancer diagnosis and mortality in people with severe mental illness: results from Australia’s National Bowel Cancer Screening Programme. Epidemiology and Psychiatric Sciences, 33 e79, 1-8. doi: 10.1017/s2045796024000787

Rates of colorectal cancer diagnosis and mortality in people with severe mental illness: results from Australia’s National Bowel Cancer Screening Programme

2024

Journal Article

Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin - a case series (vol 13, 20451253231165169, 2023)

Prasad, Femin, De, Riddhita, Korann, Vittal, Chintoh, Araba F., Remington, Gary, Ebdrup, Bjorn H., Siskind, Dan, Knop, Filip Krag, Vilsboll, Tina, Fink-Jensen, Anders, Hahn, Margaret K. and Agarwal, Sri Mahavir (2024). Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin - a case series (vol 13, 20451253231165169, 2023). Therapeutic Advances in Psychopharmacology, 14 20451253241258536. doi: 10.1177/20451253241258536

Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin - a case series (vol 13, 20451253231165169, 2023)

2023

Journal Article

Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions

van der Horst, Marte Z., Meijer, Yoeki, de Boer, Nini, Guloksuz, Sinan, Hasan, Alkomiet, Siskind, Dan, Wagner, Elias, Okhuijsen-Pfeifer, Cynthia, Luykx, Jurjen J., Müderrisoğlu, Ahmet, Privat, Alba Toll, Bouhuis, Alde, Hasan, Alkomiet, Jongkind, Amy, Gonzalez-Pinto, Ana, Santacana, Anna Mane, D'Agostino, Armando, Ertugrul, Aygün, Yağcioğlu, Ayşe Elif Anil, Crespo-Facorro, Benedicto, Sanchez-Barbero, Bianca, Spuch, Carlos, Morgenroth, Carla Lou, de Pinedo, Carmen Fernandez, Casetta, Cecilia, Bousman, Chad, Pantelis, Christos, Ovejas-Catalán, Claudia, Garcia-Rizo, Clemente ... Ayhan, Yavuz (2023). Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions. Psychiatry Research, 330 115539. doi: 10.1016/j.psychres.2023.115539

Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions

2023

Journal Article

Preliminary results from the Australian Genetics of Bipolar Disorder Study: A nation-wide cohort

Lind, Penelope A., Siskind, Dan J., Hickie, Ian B, Colodro-Conde, Lucía, Cross, Simone, Parker, Richard, Martin, Nicholas G. and Medland, Sarah E. (2023). Preliminary results from the Australian Genetics of Bipolar Disorder Study: A nation-wide cohort. Australian and New Zealand Journal of Psychiatry, 57 (11), 1428-1442. doi: 10.1177/00048674231195571

Preliminary results from the Australian Genetics of Bipolar Disorder Study: A nation-wide cohort

2023

Journal Article

Evaluating the epidemiology of clozapine-associated neutropenia among people on clozapine across Australia and Aotearoa New Zealand: a retrospective cohort study

Northwood, Korinne, Myles, Nicholas, Clark, Scott R, Every-Palmer, Susanna, Myles, Hannah, Kisely, Steve, Warren, Nicola and Siskind, Dan (2023). Evaluating the epidemiology of clozapine-associated neutropenia among people on clozapine across Australia and Aotearoa New Zealand: a retrospective cohort study. The Lancet Psychiatry, 11 (1), 27-35. doi: 10.1016/s2215-0366(23)00343-7

Evaluating the epidemiology of clozapine-associated neutropenia among people on clozapine across Australia and Aotearoa New Zealand: a retrospective cohort study

2023

Journal Article

Prevalence of frailty in severe mental illness: findings from the UK Biobank

Warren, Nicola, Leske, Stuart, Arnautovska, Urska, Northwood, Korinne, Kisely, Steve and Siskind, Dan (2023). Prevalence of frailty in severe mental illness: findings from the UK Biobank. BJPsych Open, 9 (6) e185, 1-7. doi: 10.1192/bjo.2023.580

Prevalence of frailty in severe mental illness: findings from the UK Biobank

2023

Journal Article

Pharmacological interventions for antipsychotic-related sialorrhea: a systematic review and network meta-analysis of randomized trials

Fornaro, Michele, Caiazza, Claudio, Solini, Niccolò, De Prisco, Michele, Billeci, Martina, Vannini, Martina, Shorr, Risa, Caiolo, Stefano, Lussignoli, Marialaura, Siskind, Dan, Pigato, Giorgio, Barone, Annarita, Sambataro, Fabio, de Bartolomeis, Andrea, Correll, Christoph U. and Solmi, Marco (2023). Pharmacological interventions for antipsychotic-related sialorrhea: a systematic review and network meta-analysis of randomized trials. Molecular Psychiatry, 28 (9), 3648-3660. doi: 10.1038/s41380-023-02266-x

Pharmacological interventions for antipsychotic-related sialorrhea: a systematic review and network meta-analysis of randomized trials

2023

Journal Article

Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management

Berk, Michael, Köhler-Forsberg, Ole, Turner, Megan, Penninx, Brenda W J H, Wrobel, Anna, Firth, Joseph, Loughman, Amy, Reavley, Nicola J, McGrath, John J, Momen, Natalie C, Plana-Ripoll, Oleguer, O'Neil, Adrienne, Siskind, Dan, Williams, Lana J, Carvalho, Andre F, Schmaal, Lianne, Walker, Adam J, Dean, Olivia, Walder, Ken, Berk, Lesley, Dodd, Seetal, Yung, Alison R and Marx, Wolfgang (2023). Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management. World Psychiatry, 22 (3), 366-387. doi: 10.1002/wps.21110

Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management

2023

Journal Article

Reversal learning in those with early psychosis features contingency-dependent changes in loss response and learning

Baker, Andrea, Suetani, Shuichi, Cosgrove, Peter, Siskind, Dan, Murray, Graham K., Scott, James G. and Kesby, James P. (2023). Reversal learning in those with early psychosis features contingency-dependent changes in loss response and learning. Cognitive Neuropsychiatry, 28 (5), 342-360. doi: 10.1080/13546805.2023.2259019

Reversal learning in those with early psychosis features contingency-dependent changes in loss response and learning

2023

Journal Article

Making meaning of multimorbidity and severe mental illness: a viewpoint

Halstead, Sean, Siskind, Dan and Warren, Nicola (2023). Making meaning of multimorbidity and severe mental illness: a viewpoint. Australian and New Zealand Journal of Psychiatry, 58 (1), 12-20. doi: 10.1177/00048674231195560

Making meaning of multimorbidity and severe mental illness: a viewpoint

2023

Journal Article

Verbal and visual learning ability in patients with treatment-resistant schizophrenia: a 1-year follow-up study

Arnautovska, Urska, Vitangcol, Kathryn, Kesby, James P., Warren, Nicola, Rossell, Susan L., Neill, Erica, Harris, Anthony, Galletly, Cherrie, Castle, David and Siskind, Dan (2023). Verbal and visual learning ability in patients with treatment-resistant schizophrenia: a 1-year follow-up study. Schizophrenia Research: Cognition, 33 100283, 100283. doi: 10.1016/j.scog.2023.100283

Verbal and visual learning ability in patients with treatment-resistant schizophrenia: a 1-year follow-up study

2023

Journal Article

Guía internacional para una dosificación más segura de la clozapina en adultos mediante el uso de 6 titulaciones personalizadas de dosis basados en la etnicidad, la proteína C reactiva y los niveles de clozapina

de Leon, Jose, Schoretsanitis, Georgios, Smith, Robert L., Molden, Espen, Solismaa, Anssi, Seppälä, Niko, Kopeček, Miloslav, Švancer, Patrik, Olmos, Ismael, Ricciardi, Carina, Iglesias-Garcia, Celso, Iglesias-Alonso, Ana, Spina, Edoardo, Ruan, Can-Jun, Wang, Chuan-Yue, Wang, Gang, Tang, Yi-Lang, Lin, Shih-Ku, Lane, Hsien-Yuan, Kim, Yong Sik, Kim, Se Hyun, Rajkumar, Anto P., González-Esquivel, Dinora F., Jung-Cook, Helgi, Baptista, Trino, Rohde, Christopher, Nielsen, Jimmi, Verdoux, Hélène, Quiles, Clelia ... Müller, Daniel J. (2023). Guía internacional para una dosificación más segura de la clozapina en adultos mediante el uso de 6 titulaciones personalizadas de dosis basados en la etnicidad, la proteína C reactiva y los niveles de clozapina. Psiquiatría Biológica, 30 (3) 100415. doi: 10.1016/j.psiq.2023.100415

Guía internacional para una dosificación más segura de la clozapina en adultos mediante el uso de 6 titulaciones personalizadas de dosis basados en la etnicidad, la proteína C reactiva y los niveles de clozapina

2023

Journal Article

An international research agenda for clozapine-resistant schizophrenia

Luykx, Jurjen J, Gonzalez-Diaz, Jairo M, Guu, Ta-Wei, van der Horst, Marte Z, van Dellen, Edwin, Boks, Marco P, Guloksuz, Sinan, DeLisi, Lynn E, Sommer, Iris E, Cummins, Russel, Shiers, David, Lee, Jimmy, Every-Palmer, Susanna, Mhalla, Ahmed, Chadly, Zohra, Chan, Sherry K W, Cotes, Robert O, Takahashi, Shun, Benros, Michael E, Wagner, Elias, Correll, Christoph U, Hasan, Alkomiet, Siskind, Dan, Endres, Dominique, MacCabe, James and Tiihonen, Jari (2023). An international research agenda for clozapine-resistant schizophrenia. The Lancet Psychiatry, 10 (8), 644-652. doi: 10.1016/S2215-0366(23)00109-8

An international research agenda for clozapine-resistant schizophrenia

2023

Journal Article

Patient and clinician experience of using telehealth during the COVID-19 pandemic in a public mental health service in Australia

Robinson, Lewis, Parsons, Charles, Northwood, Korinne, Siskind, Dan and McArdle, Peter (2023). Patient and clinician experience of using telehealth during the COVID-19 pandemic in a public mental health service in Australia. Schizophrenia Bulletin Open, 4 (1) sgad016, 1-7. doi: 10.1093/schizbullopen/sgad016

Patient and clinician experience of using telehealth during the COVID-19 pandemic in a public mental health service in Australia

Current funding

  • 2024 - 2028
    A hybrid-II implementation-effectiveness trial of a peer-supported self-management tool for young people in preparation for early intervention in psychosis service discharge (MY PREP-ED) (Ex USYD)
    Medical Research Futures Fund
    Open grant
  • 2023 - 2028
    Self-care of Multimorbidity in schizophrenia supported by Peer workers: a Co-designed health Information Technology (SiMPlicITy) (externally led NHMRC 2022 Targeted Call administered via Uni of Syd)
    University of Sydney
    Open grant
  • 2023 - 2027
    Using risk profiles to overcome challenges in incorporating polygenic risk scores into clinical mental health practice (QIMR administered MRFF Genomics Health Future Mission grant)
    Queensland Institute of Medical Research
    Open grant
  • 2022 - 2029
    Schizophrenia and Weight Improvement From Tirzepatide (SWIFT)
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2021 - 2027
    Mental Health Australia General Clinical Trial Network (MAGNET) (MRFF Million Minds Mental Health Research Grant Led by Deakin University)
    Deakin University
    Open grant
  • 2021 - 2025
    Reducing the mortality gap for people with schizophrenia
    NHMRC Investigator Grants
    Open grant
  • 2020 - 2026
    Helping people with schizophrenia living longer, healthier lives
    Queensland Advancing Clinical Research Fellowship
    Open grant
  • 2019 - 2025
    What is the impact of the National Bowel Cancer Screening Program on colorectal cancer outcomes for people over the age of 50 with severe mental illness?
    Cancer Council Australia
    Open grant

Past funding

  • 2023 - 2024
    Cannabidiol (CBD) for Clozapine Refractory Schizophrenia (CanCloz)
    University of Sydney
    Open grant
  • 2022 - 2024
    A 40-year life course study of the effects of child maltreatment using linked birth cohort and administrative health data
    Metro South Health Research Support Scheme Project Grant
    Open grant
  • 2019 - 2021
    Identifying and treating patients with psychosis who are positive to anti-neuronal antibodies
    NHMRC Project Grant
    Open grant
  • 2019 - 2022
    Identifying and treating patients with psychosis who are positive to anti-neuronal antibodies (NHMRC Project Grant led by QIMR)
    Queensland Institute of Medical Research
    Open grant
  • 2018 - 2020
    The efficacy of adjunctive metformin to attenuate weight gain and visceral adiposity, and prevent conversion to diabetes in people with schizophrenia newly commenced on clozapine
    Society for Mental Health Research Inc
    Open grant
  • 2018 - 2019
    The efficacy of adjunctive metformin to attenuate weight gain and visceral adiposity, and prevent conversion to diabetes in people with schizophrenia newly commenced on clozapine
    The Australian Diabetes Society
    Open grant
  • 2017 - 2018
    Avant Doctors in Training Research Scholarship Program 2017
    Avant Mutual Group Limited
    Open grant
  • 2017 - 2019
    A comparison study of three physical activity measurement tools examining acceptability in people with psychotic disorders
    Society for Mental Health Research Inc
    Open grant
  • 2017 - 2019
    Acceptability of physical activity measures in people with psychotic disorders
    Royal Australian & New Zealand College Psychiatrists
    Open grant
  • 2016 - 2019
    Cardiometabolic Health of People with Severe and Persistent Mental Illness
    NHMRC Early Career Fellowships
    Open grant
  • 2016 - 2019
    N-Acetyl Cysteine In Schizophrenia Resistant to Clozapine: A Double-Blind Randomised Placebo-Controlled Trial Targeting Negative Symptoms (NHMRC Project grant administed by Uni Melbourne)
    University of Melbourne
    Open grant
  • 2015 - 2017
    Vaporising smoking-related harms in people with severe and persistent mental illness: A study of the acceptability of vaporised nicotine products for smoking cessation or long-term substitution
    Monash University
    Open grant
  • 2015 - 2017
    Quantifying the burden of perinatal depression in Australia and New Zealand
    RANZCP Pat, Toni and Peter Kinsman Research Scholarship
    Open grant
  • 2013 - 2016
    A MAP to better care: Applying the principles of advanced directives and motivational interviewing to discharge planning for psychiatric patients
    Australian Centre for Health Services Innovation
    Open grant

Availability

Professor Dan Siskind is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

Contact Professor Dan Siskind directly for media enquiries about:

  • Cardiometabolic co-morbidity of schizophrenia
  • Treatment Refractory Schizophrenia

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au